These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34087980)

  • 21. Development of induced pluripotent stem cells from a patient with hypertrophic cardiomyopathy who carries the pathogenic myosin heavy chain 7 mutation p.Arg403Gln.
    Holliday M; Ross SB; Lim S; Mangala M; Hill A; Szappanos HC; Hool L; Semsarian C
    Stem Cell Res; 2018 Dec; 33():269-273. PubMed ID: 30508693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole-exome sequencing identifies rare compound heterozygous mutations in the MYBPC3 gene associated with severe familial hypertrophic cardiomyopathy.
    Zhou N; Qin S; Liu Y; Tang L; Zhao W; Pan C; Qiu Z; Wang X; Shu X
    Eur J Med Genet; 2018 Aug; 61(8):434-441. PubMed ID: 29524613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of an induced pluripotential stem cell (iPSC) line from a patient with hypertrophic cardiomyopathy carrying myosin binding protein C (MYBPC3) c.3369-3370 insC mutation.
    Jin J; Lu L; Chen J; Wang K; Han J; Xue S; Weng G
    Stem Cell Res; 2020 Dec; 50():102144. PubMed ID: 33388705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The «Amish» NM_000256.3:c.3330+2T>G splice variant in MYBPC3 associated with hypertrophic cardiomyopathy is an ancient Swiss mutation.
    Redin C; Pavlidou DC; Bhuiyan Z; Porretta AP; Monney P; Bedoni N; Maurer F; Sekarski N; Atallah I; Émeline D; Jeanrenaud X; Pruvot E; Fellay J; Superti-Furga A
    Eur J Med Genet; 2022 Dec; 65(12):104627. PubMed ID: 36162733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of two iPSC clones (MHHi021-A and MHHi021-B) from a patient with hypertrophic cardiomyopathy with p.Arg723Gly mutation in the MYH7 gene.
    Merkert S; Wunderlich S; Beier J; Franke A; Schwanke K; Göhring G; Kraft T; Francino A; Zweigerdt R; Martin U
    Stem Cell Res; 2021 Apr; 52():102208. PubMed ID: 33578365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of human induced pluripotent stem cell lines derived from four patients with a pathogenic ALPK3 variant associated with adult-onset hypertrophic cardiomyopathy (HCM).
    Cheawsamoot C; Ramchandani R; Ameen M; Arthur Ataam J; Khongphatthanayothin A; Shotelersuk V; Karakikes I
    Stem Cell Res; 2023 Dec; 73():103233. PubMed ID: 37944352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of induced pluripotent stem cell lines from two unrelated individuals with familial hypertrophic cardiomyopathy carrying the MYBPC3 missense c.1484G>A mutation.
    Ribeiro M; Martins S; Carvalho T; Furtado M; Sampaio Cabral J; Brito D; Carmo-Fonseca M; da Rocha ST
    Stem Cell Res; 2024 Feb; 74():103282. PubMed ID: 38104429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An induced pluripotent stem cell line (GZHMCi004-A) derived from a fetus with heterozygous G380R mutation in FGFR3 gene causing achondroplasia.
    Li N; Lin SM; Li Y; Sun J; Zhang L; Chen M
    Stem Cell Res; 2021 May; 53():102322. PubMed ID: 33848795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applying Patient-Specific Induced Pluripotent Stem Cells to Create a Model of Hypertrophic Cardiomyopathy.
    Dementyeva EV; Medvedev SP; Kovalenko VR; Vyatkin YV; Kretov EI; Slotvitsky MM; Shtokalo DN; Pokushalov EA; Zakian SM
    Biochemistry (Mosc); 2019 Mar; 84(3):291-298. PubMed ID: 31221067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An induced pluripotent stem cell line (YCMi006-A) generated from a patient with hypertrophic cardiomyopathy who carries the ACTA1 mutation p.Ile343Met.
    Kim H; Kim HJ; Oh J; Lee ST; Won D; Choi HK; Choi JR; Kim S; Kim HP; Kim SJ; Park SW; Kang SM; Lee SH
    Stem Cell Res; 2022 Aug; 63():102874. PubMed ID: 35917599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of an induced pluripotent stem cell line (SYSUi005-A) from a patient with hypertrophic cardiomyopathy.
    Zhang C; Shi J; Zhang Z; Zhao Q; Xie M; Chen Y; Xiang Q
    Stem Cell Res; 2022 Jan; 58():102626. PubMed ID: 34942479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes.
    Tanaka A; Yuasa S; Mearini G; Egashira T; Seki T; Kodaira M; Kusumoto D; Kuroda Y; Okata S; Suzuki T; Inohara T; Arimura T; Makino S; Kimura K; Kimura A; Furukawa T; Carrier L; Node K; Fukuda K
    J Am Heart Assoc; 2014 Nov; 3(6):e001263. PubMed ID: 25389285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of two clonal iPSC lines, ICGi019-A and ICGi019-B, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.M659I mutation in MYH7.
    Dementyeva EV; Kovalenko VR; Zhiven MK; Ustyantseva EI; Kretov EI; Vyatkin YV; Zakian SM
    Stem Cell Res; 2020 Jul; 46():101840. PubMed ID: 32422568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of an iPSC line (ZZUNEUi021-A) from a hypertrophic cardiomyopathy patient with TNNT2 mutation.
    Dong Y; Li X; Fu W; Tian X; Guo G; Peng Y; Zhai Y; Zhao J; Ding Z; Zhao X; Dong J
    Stem Cell Res; 2022 Jan; 58():102622. PubMed ID: 34929444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of a hiPSC line ZZUNEUi007-A from a patient with hypertrophic cardiomyopathy caused by mutation in MYH7.
    Li X; Liu Y; Liu F; Wang X; Liu M; Du W; Zhao J; Wang M; Hu L; Wang C; Fu W; Dong J; Zhao X
    Stem Cell Res; 2020 Mar; 43():101699. PubMed ID: 31931472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
    Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myosin-binding Protein C Compound Heterozygous Variant Effect on the Phenotypic Expression of Hypertrophic Cardiomyopathy.
    Rafael JF; Cruz FEDS; Carvalho ACC; Gottlieb I; Cazelli JG; Siciliano AP; Dias GM
    Arq Bras Cardiol; 2017 Apr; 108(4):354-360. PubMed ID: 28538763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of iPSC line from MYH7 R403L mutation carrier with severe hypertrophic cardiomyopathy and isogenic CRISPR/Cas9 corrected control.
    Fontaine V; Duboscq-Bidot L; Jouve C; Hamlin M; Curjol A; Briand V; Janiak P; Hulot JS; Pruniaux-Harnist MP; Charron P; Villard E
    Stem Cell Res; 2021 Apr; 52():102245. PubMed ID: 33610018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variable cardiac myosin binding protein-C expression in the myofilaments due to MYBPC3 mutations in hypertrophic cardiomyopathy.
    Parbhudayal RY; Garra AR; Götte MJW; Michels M; Pei J; Harakalova M; Asselbergs FW; van Rossum AC; van der Velden J; Kuster DWD
    J Mol Cell Cardiol; 2018 Oct; 123():59-63. PubMed ID: 30170119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An induced pluripotent stem cell line (GZHMCi003-A) derived from a fetus with exon 3 heterozygous deletion in RUNX2 gene causing cleidocranial dysplasia.
    Chen M; Lin SM; Li N; Li Y; Li Y; Zhang L
    Stem Cell Res; 2021 Mar; 51():102166. PubMed ID: 33477036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.